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1. Introduction 
The biological action of the gastrin hormones is 
confined to the C-terminal tetrapeptide amide Trp- 
Met-Asp-Phe-NH2 [2-51. The physiological role of 
the remaining peptide sequences is, however, still 
obscure, as no clear evidecce for a specific function 
has been found. Among the various possibilities the 
-(G~u)~- sequence common to big gastrin, little 
gastrin and minigastrin could be suited for the bind- 
ing of metal ions such as calcium or magnesium. 
To test this hypothesis we studied the interaction 
of Nle”-minigastrin I (Nle”-HG-13) with Ca”. The 
investigation was carried out in trifluoroethanol as 
the solvent, which mimics the lipophilic environ- 
ment of a membrane [6], where the binding process 
could occur. 
2. Materials and methods 
The synthesis and characterization of the peptides 
used here will be reported in [7]. Reagent grade 
CaClz .2 HZ0 and CaC104. 4 Hz0 were purchased 
from Fluka AG, Buchs; Uvasol 2,2,2-Trifluoroethanol 
(TFE) was obtained from Merck AG, Darmstadt. 
Solutions of Ca2’ were prepared by dissolving 
known amounts of CaC12 or perchlorate in TFE. The 
metal ion concentration was precisely determined by 
* According to the revised structure [ I] for the natural hor- 
mone, the correct name for the tridecapeptide amide 
H-Leu-(Glu),-Ala-Tyr-GlyTrp-NleAsp-Nle~Asp-Phe-NH2 
is Des-Trp*-Nle’2-minigastrin I 
‘! On leave from: Istituto di Chimica Organica, Padova, Italy 
158 
atomic absorption measurements. The hormone con- 
centrations, ranging from 2 X lo-‘-7.6 X 10e7 M, 
were determined by the weight and peptide content 
of the samples and/or by absorption measurements in 
the near UV. CD measurements were performed at 
25°C using a Mark III Jobin-Yvon Dichrograph. In 
the spectra reported here, [6] R represents the ellipti- 
city value/mol peptide residues. UV measurements 
were made with a Carry 118C recording spectrometer. 
Atomic absorption data were obtained using a Perkin 
Elmer 360 AA spectrometer. 
Of the experimental methods reported for the 
characterization of metal ion interactions with pep- 
tides, only CD measurements were suitable here. In 
fact the fluorescent probes Tyr and Trp present in 
Nle”-HG-13 in the positions 8 and 10, respectively, 
were not sensitive enough to the binding process; 
NMR investigations were prevented by precipitation 
of the Ca-adducts at high (alO-* M) hormone levels; 
equilibrium dialysis and ion-sensitive electrodes could 
not be employed due to the low Mr of Nle” -HG-13 
(1628) and/or to the nature of the solvent. 
3. Results and discussion 
Upon addition of Ca2+ to a dilute (2 X lo-’ M) 
solution of Nle” -HG-13 in TFE a dramatic change in 
the CD pattern of the hormone is observed (fig. 1). 
The amount of metal ion required to fully perform 
the conformational transition is rather low and related 
to the hormone concentration. Therefore, Ca*+ strong-’ 
ly interact with the Nle”-HG-13 molecule. The CD 
pattern of the Ca-bound peptide is characterized by a 
minimum absorption at 19.5 nm and bv a negative 
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Fig.1. CD spectra of Nle”-HG-13 in TFE at different Ca/pep- 
tide ratios (R): (1) R = 0; (2) R = 0.5; (3) R = 1.0; (4) R = 
1.5; (5) R = 2.2; (6) R = 4/6. Peptide was 2.1 X 10m5 M. 
shoulder at 215 nm with molar ellipticities/residue of 
-10 900 and -2300, respectively. These data indi- 
cate that coordination to the metal ion forces Nle”- 
HG-13 into an essentially disordered conformation. 
The results obtained at 3 different hormone levels 
(over 2 X 10-s-8 X 10e7 M) are summarized in fig.2, 
where the relative change in circular dichroism (0 ./0,) 
is reported as a function of the Ca/peptide ratio (R). 
It clearly appears that 2 Ca2+ can bind to Nle” -HG-13 
under our experimental conditions. If further binding 
occurs after the structural change, it cannot obviously 
be detected by CD measurements. 
Due to the low hormone concentration we used, it 
is reasonable to assume that no intermolecular gastrin- 
Ca-gastrin interactions occur, so that 1 Nle’l-HG-13 
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Fig.2. Binding curves for the system Ca-Nle”-HG-13 in TFE 
at different hormone levels: (m,a,X) 2.1 X 10m5 M; (a,~) 
4.2 X 1Om6 M; (a,*) 7.6 X IO-’ M. Solid lines are the theore- 
tical binding curves with K, = m and K, = 4.3 X lo5 at the 
above hormone levels. 
molecule/complex unit can be considered. 
From fig.2 it also appears that the conformational 
change is directly related to the binding process, as 
the relative CD modification at a given wavelength is 
proportional to the amount of added calcium at suf- 
ficiently high gastrin concentrations. 
About 50% of the spectrd change therefore can be 
attributed to the binding of the first metal ion. and 
the remaining 50% to the binding of the second Ca2+. 
While no complex dissociation takes place by lowering 
the hormone concentration by a factor of 25 when 
R = 1 (all experimental points fall on the same straight 
line), different curves are obtained as a function of 
the peptide concentration at R > 1. As a consequence 
the affinity constant for the first binding defined as: 
[Nle”-HG-13-Ca] 
K1 = [Nleir-HG-131 . [Ca”‘] 
will be substantially higher than the corresponding 
constant for the second binding defined as: 
K = [Nle”-HG-13-Ca2] 
’ [Nle”-HG-13-Ca] . [Ca”‘] 
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A precise value for Kr cannot be inferred from our 
data, but it should exceed 5 X IO’, as no detectable 
dissociation occurred at -8 X 10d7 M complex. 
For the second binding constant we obtained K2 = 
4.3 * 0.3 X IO’, using the graphical methods in [8]. 
The high values of K, and K2 suggest a specific inter- 
action between Ca’+ and the hormone analogue. The 
remarkable differences in the two constants either 
reflect the existence of intrinsically different binding 
sites or a negative cooperativity between identical 
sites. 
The question now arises on what is the nature of 
the ligand groups in Me” -HG-I 3. Since Ca’+ generally 
binds to oxygen atoms, the possibilities are restricted 
to two candidates: the carboxylate groups of the Glu 
and/or Asp residues and the carbony moieties of the 
peptide group. 
To shed light on this problem we investigated the 
0.0 r 
binding properties of Ca’+ to a sample of Me”-HG-13 
in which all Glu and Asp residues are protected by 
t-butyl groups (Boc-Leu- [Glu(OBur)] s-Ala- 
Tyr(But)-Gly-Trp-Me-Asp(OBur)-Phe-NH,). The 
CD spectrum of this peptide in TFE closely resembles 
that of the corresponding deblocked hormone 
(fig.3(1)), so that the presence of the t-butyl groups 
does not appear to substantially affect the conforma- 
tional properties of Nle’r-HG-13. The metal ion 
clearly interacts with thepeptide, in spite of the 
absence of free carboxylate groups (fig.3). However, 
in this case we obtain evidence of specific binding for 
only 1 metal ion. The conclusion can be drawn that 
the presence of negatively charged Glu and/or Asp 
residues is essential for the binding of at least 1 Ca2+ 
to deprotected Me “-HG-13. On the other hand 
involvement of peptide oxygens in the binding process 
is suggested by the dramatic conformational change 
to a disordered structure caused by Ca*+ addition to 
the hormone (which would not be expected if only 
sidechain groups were bound to the metal ion), and 
by the data on the crystal structure of several Ca-pro- 
teins in which at least one carbonyl moiety from the 
peptide group is found in the coordination sphere of 
calcium [9]. 
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Fig.3. CD spectra of f-butylated BOC-Nle”-HG-I 3 in TFE at 
different Ca/peptide ratios (R): (1) R = 0; (2) R = 0.5; (3) 
R = 1.0; (4) R = 1.5; (5) R = 2.0. Peptide was 2.46 X 10d5 M 
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Preliminary results indicate that also Mg2+ strongly 
interact with Nle”-HG-13. Further studies on the 
binding properties of our peptide hormones with 
alkaline earth and other metal ions are in progress. 
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